PT  - JOURNAL ARTICLE
AU  - Boltz, Kathy
ED  - Gadelha, Monica R.
TI  - Biochemical Control of Acromegaly Continued in PAOLA Trial Extension
DP  - 2015 Jun 18
TA  - MD Conference Express
PG  - 10--10
VI  - 15
IP  - 4
4099  - http://mdc.sagepub.com/content/15/4/10.2.short
4100  - http://mdc.sagepub.com/content/15/4/10.2.full
AB  - This extension study of the phase 3 PAOLA trial found that pasireotide LAR may be a viable, long-term treatment option for patients with acromegaly that is inadequately controlled with first-generation somatostatin analogues. Biochemical control of growth hormone and normalized insulin-like growth factor 1 continued through extension week 28.